Award given for saving millions of lives by providing sustained access to childhood vaccines around the globe
Geneva, 10 September 2019 – The Albert and Mary Lasker Foundation announced today that Gavi, the Vaccine Alliance has received the prestigious 2019 Lasker~Bloomberg Public Service Award for providing sustained access to childhood vaccines in the world’s poorest countries, saving millions of lives and highlighting the power of immunisation to prevent diseases.
“It is a great honour for us to receive such a prestigious Award,” said Dr Seth Berkley, CEO of Gavi the Vaccine Alliance. “Since its creation in 2000 at Davos, Gavi has been making it possible for the world’s most vulnerable children to receive the vaccines they need to live healthy, successful lives. Our collective work as an Alliance has prevented more than 13 million deaths in developing countries while child mortality was halved largely thanks to immunisation. I couldn’t be prouder of what we have accomplished together.”
Our collective work as an Alliance has prevented more than 13 million deaths in developing countries while child mortality was halved largely thanks to immunisation. I couldn’t be prouder of what we have accomplished together.
Gavi now helps immunise around half the world’s children through a unique public-private partnership that brings together governments, private donors, industry, civil society organisations and international organisations to deliver life-saving vaccination programmes in low-income countries. Driven by country leadership, Gavi offers vaccines at a lower cost while countries take a share of costs and build sustainable immunisation programme before transitioning out of Gavi support.
“On behalf of the hundreds of thousands of vaccinators, health workers and partners that make up our Vaccine Alliance, we are delighted to receive the Lasker~Bloomberg Public Service Award,” said Dr Ngozi Okonjo-Iweala, Chair of the Gavi Board. “All children – regardless of whether they are girls or boys, where they live or how poor they are – have the right to be protected against deadly diseases. However, nearly 20 million children are still missing out on a full course of the most basic vaccines, and more than 10 million do not even receive the first dose. Building on nearly two decades of steady progress, Gavi will redouble efforts in the coming years to extend immunisation services to those communities missed today.”
On behalf of the hundreds of thousands of vaccinators, health workers and partners that make up our Vaccine Alliance, we are delighted to receive the Lasker~Bloomberg Public Service Award.
Every year since 1945, the Lasker Foundation has presented a range of awards for some of the most accomplished people and institutions involved in breakthrough biological discoveries and clinical health advances. The Lasker~Bloomberg Public Service Award honours exceptional individuals or organisations whose impact on public health or public service has enlarged the possibilities for medical research and the health sciences.
The Lasker Foundation will formally present the Public Service Award to Gavi, the Vaccine Alliance at a ceremony on September 20 in New York City.
Since 2000, Gavi has supported more than 460 vaccine introductions and campaigns, providing funding for vaccine procurement and strengthening health systems. Gavi also funds the global stockpiles of cholera, yellow fever and meningitis vaccines, and supports measles response. Gavi stimulates the dissemination of new vaccines such as the Ebola vaccine that is now being used in the Democratic Republic of the Congo. Gavi is funded through contributions by governments as well as Foundations and the private sector.
The Alliance recently unveiled in Japan its 2021-25 Investment Opportunity calling on donors to back plans to immunise an additional 300 million children in developing countries against deadly diseases, saving a further seven to eight million lives. The replenishment process will culminate in a special event hosted by the UK government, mid-2020.
Notes to editors
About Gavi, the Vaccine Alliance
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunise a whole generation – over 760 million children – and prevented more than 13 million deaths, helping to halve child mortality in 73 developing countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningitis and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation and reaching the unvaccinated children still being left behind, employing innovative finance and the latest technology – from drones to biometrics – to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at www.gavi.org and connect with us on Facebook and Twitter.
The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. View the full list of donor governments and other leading organizations that fund Gavi’s work here.
Latest news
View allGavi statement on mpox emergency in Africa
Gavi, the Vaccine Alliance continues to be deeply concerned about the escalating mpox emergency on the African continent.
ASEAN health ministers pledge boldly to boost immunization in the region
ASEAN Member States have committed to boosting immunization coverage through a combination of innovative financing and domestic funding.
Mozambique introduces malaria vaccines into routine immunization
Mozambique has today introduced the lifesaving malaria vaccine into routine immunization, a critical step forward to revitalize the fight against malaria and improve children’s survival.
Ada Hegerberg leads unfair football match at the Norway Cup to call for equal vaccine access for all
Ada Hegerberg and Gavi, the Vaccine Alliance gathered young people from around the world at the coveted Friendship Match during the Norway Cup to illustrate how unequal access to vaccines worldwide gives children an unfair start in life.
The Syrian Ministry of Health (MOH), supported by WHO, UNICEF and Gavi, the Vaccine Alliance, has launched the second round of Big Catch-Up vaccination activity this week.
61,374 girls in Timor-Leste to receive HPV vaccine to combat cervical cancer
Timor-Leste launches HPV Vaccine for 11–14 years girls. With support from partners, the vaccine will help protect girls and women against cervical cancer: a common yet preventable disease.
The allocation follows a Gavi Board decision in December 2023 to approve US$ 290 million funding for the “Big Catch-Up” initiative.
Gavi and Côte d'Ivoire commit to a successful programmatic and financial transition
Côte d’Ivoire commits to fully finance its routine immunisation programme over the next five years to ensure sustainability beyond Gavi support.
South Sudan Launches R21 Malaria Vaccine Rollout to Protect Children
In a historic move to combat the devastating impact of malaria, the Ministry of Health, in partnership with UNICEF and the World Health Organization and Gavi, The Vaccine Alliance, today launched the nationwide rollout of the R21 malaria vaccine…
